RNA-Based Therapeutics & Vaccines Summit Asia

November 18–20, 2025 | Incheon, South Korea


아시아 최초로 개최되는 RNA 기반 치료제·백신 서밋이 오는 11월, 한국 인천에서 개최됩니다.
이번 서밋은 한국, 중국, 일본, 싱가포르, 미국 등 전 세계 RNA 분야 리더 및 제약바이오 전문가들이 참여해 mRNA, sa-RNA, circular RNA, siRNA 등에 대한 최신 연구를 기반하는 팬데믹 대응부터 희귀질환, 항암 백신까지 폭넓은 주제를 다룰 예정입니다. 


Pfizer, GC Biopharma, Abogen, WestGene 등 글로벌 기업들의 발표가 예정되어 있으며, 아시아 시장에 특화된 규제 동향, CMC 확장, 임상 전략에 관한 실질적인 인사이트를 얻을 수 있는 기회도 마련됩니다. RNA 산업의 미래를 함께 열어갈 이번 서밋에 많은 관심과 참여 바랍니다.


사전등록 및 보다 자세한 정보는 다음 홈페이지에서 가능합니다: https://ter.li/q7cgbk


The wait is over. The official program for the inaugural RNA-Based Therapeutics & Vaccines Summit Asia has just been released, marking a major milestone for RNA innovation in the region.

Taking place from November 18–20, 2025 in Incheon, South Korea, this landmark event will unite over 20 global biopharma leaders from across South Korea, China, Japan, Singapore, the United States, and beyond. As Asia’s most comprehensive, industry-focused forum dedicated to RNA medicines, the summit will showcase the latest in mRNA, sa-RNA, circular RNA, and siRNA advancements — accelerating the development of safe and effective RNA therapeutics for patients worldwide.

■ Highlights of the 2025 Program Include:

  • Groundbreaking data presentations and real-world case studies
  • Innovation across pandemic preparedness, personalised cancer vaccines, and protein replacement therapies
  • Exclusive networking with 80+ senior decision-makers, including CxOs, R&D leaders, and Business Development executives
  • Insight into regulatory, CMC, and commercialization pathways in Asia and globally

■ A Glimpse at the Esteemed Speaker Faculty:

  • Kee-Jong Hong, Professor, Gachon University School of Medicine & Director General, Korea mRNA Vaccine Initiative (KmVAC)
  • Bo Ying, CEO, Abogen Bioscience
  • Xiangrong Song, CEO & Co-Founder, WestGene Biopharma
  • Yeong-Chan Ahn, Business Development Director, SML Biopharm
  • Sang Hwan Seo, Director, International Vaccine Institute
  • Yu Pang, Senior Scientist, Pfizer
  • Yasumasa Ota, mRNA Technology Leader, Meiji Seika Pharma
  • Sunghoon Ma, Head of Medicine Discovery & Development, GC Biopharma
  • Adam Zhao, CEO, Anlong Bio

■ Download the full program → https://ter.li/a10ijw

This exclusive summit is your opportunity to connect with the leaders shaping the future of RNA in Asia. Whether you're advancing early discovery, scaling CMC, or preparing for clinical trials and commercialization, this forum will offer the insights and partnerships needed to accelerate your progress.

■ Press Contact: Stephanie Nketia, Senior Marketing Manager / info@hansonwade.com, +1 617 455 4188  / https://rnatherapeutics-vaccines-asia.com